Related Experiment Video
Updated: Aug 13, 2026

09:45
Host Cell Protein Analysis using Enrichment Beads Coupled with Limited Digestion
Published on: January 19, 2024
Host Cell Protein Challenges in Antibody Processing: Insights Into Persistence and Mitigation Strategies
Younghoon Oh1, Andrew Cooke1, Harshal Soni1
1Johnson & Johnson, Protein Therapeutics API Development, Malvern, Pennsylvania, USA.
Biotechnology and Bioengineering
|August 12, 2026
Summary
Host cell proteins (HCPs) are a persistent challenge in biopharmaceutical purification. Understanding HCP mechanisms guides proactive strategies for improved product quality and patient safety.
Area of Science:
- Biopharmaceutical Manufacturing
- Protein Chemistry
- Process Development
Background:
- Host cell proteins (HCPs) pose a significant challenge in biopharmaceutical purification, impacting product quality, patient safety, and regulatory adherence.
- Recent advancements have elucidated the mechanisms behind HCP persistence, enabling a shift from reactive to proactive control strategies.
Purpose of the Study:
- To review current knowledge on HCP persistence mechanisms, specifically within antibody production.
- To examine how HCP properties influence persistence and inform mitigation strategies.
- To offer a forward-looking perspective for developing robust HCP control strategies.
Main Methods:
- Literature review and synthesis of current research on HCP persistence.
- Analysis of specific HCP properties contributing to their evasion of removal during purification.
- Examination of design-based strategies for HCP mitigation.
Main Results:
- Insights into HCP mechanisms clarify why certain proteins resist removal during purification processes.
- Understanding specific HCP properties is crucial for designing effective removal strategies.
- Proactive, design-based approaches are emerging as superior to reactive methods.
Conclusions:
- A deeper understanding of HCP persistence mechanisms is essential for improving biopharmaceutical purification.
- Future research should focus on leveraging these insights to develop robust, proactive HCP control strategies.
- This review provides a foundation for guiding future development in HCP management for enhanced biomanufacturing.
Related Concept Videos
Antibody Actions
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Humoral Immune Responses
Overview
B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.

